142 related articles for article (PubMed ID: 28587825)
1. Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities.
Shan WG; Wang HG; Chen Y; Wu R; Wen YT; Zhang LW; Ying YM; Wang JW; Zhan ZJ
Bioorg Med Chem Lett; 2017 Aug; 27(15):3450-3453. PubMed ID: 28587825
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Oct; 139():836-848. PubMed ID: 28865279
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents.
Tang K; Huang Q; Zeng J; Wu G; Huang J; Pan J; Lu W
Molecules; 2014 Jul; 19(7):10177-88. PubMed ID: 25025148
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antitumor evaluation of novel celastrol derivatives.
Xu M; Li N; Zhao Z; Shi Z; Sun J; Chen L
Eur J Med Chem; 2019 Jul; 174():265-276. PubMed ID: 31051401
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-tumor activity study of water-soluble PEG-celastrol coupling derivatives as self-assembled nanoparticles.
Shan WG; Wang HG; Wu R; Zhan ZJ; Ma LF
Bioorg Med Chem Lett; 2019 Mar; 29(5):685-687. PubMed ID: 30728110
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
Zhang HJ; Zhang GR; Piao HR; Quan ZS
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
[TBL] [Abstract][Full Text] [Related]
7. Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Sep; 138():422-437. PubMed ID: 28688281
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of antitumor activity of novel C-6 sulfhydryl-substituted and 20-substituted derivatives of celastrol.
Su D; Wei RY; Yan ZM; Zhong GH; Qin XQ; Huang ST; Long JY; Zhang FL; He P; Chen ZJ; Yan YQ; Jiang N; Tang WZ
Chem Biol Drug Des; 2023 Aug; 102(2):316-331. PubMed ID: 37156601
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of a Series of Novel Celastrol Derivatives with Amino Acid Chain.
Pang C; Luo J; Liu C; Wu X; Wang D
Chem Biodivers; 2018 May; 15(5):e1800059. PubMed ID: 29633499
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of celastrol derivatives as anticancer agents.
Tang WJ; Wang J; Tong X; Shi JB; Liu XH; Li J
Eur J Med Chem; 2015 May; 95():166-73. PubMed ID: 25812966
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents.
Li X; Ding J; Li N; Liu W; Ding F; Zheng H; Ning Y; Wang H; Liu R; Ren S
Eur J Med Chem; 2019 Oct; 179():667-679. PubMed ID: 31279299
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues.
Shao Y; Ding H; Tang W; Lou L; Hu L
Bioorg Med Chem; 2007 Aug; 15(15):5061-75. PubMed ID: 17544278
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
17. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
19. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties.
Jiang F; Wang HJ; Bao QC; Wang L; Jin YH; Zhang Q; Jiang D; You QD; Xu XL
Bioorg Med Chem; 2016 Nov; 24(21):5431-5439. PubMed ID: 27647369
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
